Concepedia

Author

Matko Čančer

Science for Life LaboratoryORCID

Also Known As

Cancer, Matko, M Cancer, M. Cancer, Matko Cancer, Matko Čančer

63

Publications

369

Citations

10

H-Index

15

Concepts

All Affiliations

Science for Life LaboratoryUppsala UniversityKarolinska InstitutetDiscovery InstituteSanford Burnham Prebys Medical Discovery Institute
MČ

About

Matko Čančer is an author at Science for Life Laboratory specializing in immunology, medicine, and inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

54

2

Immunology

2

2

54

3

Cell Biology

1

1

10

4

Orthopaedics

1

1

44

5

Rheumatology

1

1

44

Matko Čančer

×

9

Publications

286

Citations

9

H-Index

YearCitations

FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma

Aldwin Suryo Rahmanto, Vasil Savov, Andrä Brunner,

The EMBO Journal

2016

78

Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR Axis that Promotes Malignancy

Matko Čančer, Sonja Hutter, Karl O. Holmberg,

Cell stem cell

2019

64

Degradation in vivo of articular cartilage in rheumatoid arthritis by leucocyte elastase from polymorphonuclear leucocytes

M. Velvart, K Fehr, Antonio Baici,

Rheumatology International

1981

44

BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells

Matko Čančer, Lisa F. Drews, Johan Bengtsson,

Cell Death and Disease

2019

33

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Anna Borgenvik, Karl O. Holmberg, Sara Bolin,

Cancer Research

2022

24

Temporal arteritis in polymyalgia rheumatica: immune complex deposits and the role of the leukocyte elastase in the pathogenesis.

M. Velvart, Michael R. Felder, K Fehr,

PubMed

1984

11

Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus

Jing Ma, Chuan Jin, Matko Čančer,

Molecular Therapy — Oncolytics

2021

11

Novel compounds that synergize with aminoglycoside G418 or eRF3 degraders for translational readthrough of nonsense mutant <i>TP53</i> and <i>PTEN</i>

Angelos Heldin, Matko Čančer, Mireia Palomar-Siles,

RNA Biology

2023

11

Tat-PTD-Modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy

Chuan Jin, Di Yu, Matko Čančer,

Human Gene Therapy

2013

10

Page 1